Abstract
The elements which are necessary for a co-ordinated system of quality control of intravenous additive services are reviewed. It is argued that, with the use of advanced equipment, such a system can be established, even for this type of very divergent preparations. Major emphasis is placed upon in-process control, where the use of computerized systems creates the opportunity for an integrated quality control system.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Barker KN, ed. Recommendations of the NCCLVP for the compounding and administration of intravenous solutions. Bethesda: American Society of Hospital Pharmacists, 1981.
Stolar MM. National survey of hospital pharmaceutical services 1982. Am J Hosp Pharm 1983;40:963–9.
Whyte W. The influence of clean room design on product contamination. J Parenter Sci Technol 1984;38:103–7.
Thomson RG. The architectural design and detailing of pharmaceutical cleanrooms. Pharm Engineering 1985;May–June:19–24.
Kraus JJAM, Vermeij P. Verantwoorde monstemame bij controle van aseptische werkomstandigheden in ziekenhuisapotheken. Pharm Weekbl 1986;121:370–6.
Eklund LH, Montelius C. Experiences from a centralized large scale preparation of cytotoxic parenteral drugs [Abstract]. In: FIP '87 abstracts. Amsterdam: FIP, 1987:267.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vermeij, P. Quality control in intravenous additive service. Pharmaceutisch Weekblad Scientific Edition 10, 151–153 (1988). https://doi.org/10.1007/BF01959423
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01959423